Albelda SM - Search Results

1

PECAM-1 (CD31) engagement activates a phosphoinositide-independent, nonspecific cation channel in endothelial cells.

O'Brien CD, Ji G, Wang YX, Sun J, Krymskaya VP, Ruberg FL, Kotlikoff MI, Albelda SM. O'Brien CD, et al. Among authors: albelda sm. FASEB J. 2001 May;15(7):1257-60. doi: 10.1096/fj.00-0467fje. FASEB J. 2001. PMID: 11344106 No abstract available.

2

Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule.

Albelda SM, Muller WA, Buck CA, Newman PJ. Albelda SM, et al. J Cell Biol. 1991 Sep;114(5):1059-68. doi: 10.1083/jcb.114.5.1059. J Cell Biol. 1991. PMID: 1874786 Free PMC article.

3

Alternative splicing of a specific cytoplasmic exon alters the binding characteristics of murine platelet/endothelial cell adhesion molecule-1 (PECAM-1).

Yan HC, Baldwin HS, Sun J, Buck CA, Albelda SM, DeLisser HM. Yan HC, et al. Among authors: albelda sm. J Biol Chem. 1995 Oct 6;270(40):23672-80. doi: 10.1074/jbc.270.40.23672. J Biol Chem. 1995. PMID: 7559536 Free article.

4

Molecular and functional aspects of PECAM-1/CD31.

DeLisser HM, Newman PJ, Albelda SM. DeLisser HM, et al. Among authors: albelda sm. Immunol Today. 1994 Oct;15(10):490-5. doi: 10.1016/0167-5699(94)90195-3. Immunol Today. 1994. PMID: 7945775 Free article. Review.

5

Adhesion molecules and inflammatory injury.

Albelda SM, Smith CW, Ward PA. Albelda SM, et al. FASEB J. 1994 May;8(8):504-12. FASEB J. 1994. PMID: 8181668 Free article. Review.

6

Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties.

DeLisser HM, Chilkotowsky J, Yan HC, Daise ML, Buck CA, Albelda SM. DeLisser HM, et al. Among authors: albelda sm. J Cell Biol. 1994 Jan;124(1-2):195-203. doi: 10.1083/jcb.124.1.195. J Cell Biol. 1994. PMID: 8294502 Free PMC article.

7

Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression.

Sun J, Williams J, Yan HC, Amin KM, Albelda SM, DeLisser HM. Sun J, et al. Among authors: albelda sm. J Biol Chem. 1996 Aug 2;271(31):18561-70. doi: 10.1074/jbc.271.31.18561. J Biol Chem. 1996. PMID: 8702505 Free article.

8

The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivo.

Elshami AA, Cook JW, Amin KM, Choi H, Park JY, Coonrod L, Sun J, Molnar-Kimber K, Wilson JM, Kaiser LR, Albelda SM. Elshami AA, et al. Among authors: albelda sm. Cancer Gene Ther. 1997 Jul-Aug;4(4):213-21. Cancer Gene Ther. 1997. PMID: 9253506

9

Involvement of endothelial PECAM-1/CD31 in angiogenesis.

DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM. DeLisser HM, et al. Among authors: albelda sm. Am J Pathol. 1997 Sep;151(3):671-7. Am J Pathol. 1997. PMID: 9284815 Free PMC article.

10

Tyrosine residue in exon 14 of the cytoplasmic domain of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) regulates ligand binding specificity.

Famiglietti J, Sun J, DeLisser HM, Albelda SM. Famiglietti J, et al. Among authors: albelda sm. J Cell Biol. 1997 Sep 22;138(6):1425-35. doi: 10.1083/jcb.138.6.1425. J Cell Biol. 1997. PMID: 9298995 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page